Search results for "Goblet cell"

showing 5 items of 25 documents

Mucus and MUC in asthma.

2005

Asthma is characterized by chronic airway inflammation and a mucus hypersecretory phenotype comprising excess mucus secretion, goblet cell hyperplasia and submucosal gland hypertrophy. This augmented mucus secretion has been relatively undervalued in asthma compared with airway inflammation. However, mucus plugging contributes to airflow limitation and airway hyperresponsiveness, and to morbidity and mortality in asthma. We review recent contributions to this field and therapeutic avenues to control mucus hypersecretion.A distinct mucus hypersecretory phenotype may present in asthma. Overexpression of MUC5AC, MUC5B and MUC2 have been described in asthma secretions, but identification of def…

Pulmonary and Respiratory MedicineGoblet cell hyperplasiabusiness.industryMucinMucinsRespiratory Mucosarespiratory systemmedicine.diseaseMucusPhenotypeAsthmarespiratory tract diseasesMuscle hypertrophyMucusfluids and secretionsPhenotypeImmunologyChronic DiseaseMedicineHumansSecretionbusinessAirwayAsthmaCurrent opinion in pulmonary medicine
researchProduct

The association between appendicitis severity and patient age with appendiceal neoplasm histology—a population-based study

2022

Abstract Purpose Recent studies have reported alarming appendiceal tumor rates associated with complicated acute appendicitis, especially in patients presenting with a periappendicular abscess. However, the data on histology of appendiceal tumors among acute appendicitis patients is limited, especially in patient cohorts differentiating between uncomplicated and complicated acute appendicitis. We have previously reported the association of increased appendiceal tumor prevalence with complicated acute appendicitis in this population-based study. The objective of this secondary analysis was to evaluate the association of both appendicitis severity and patient age with appendiceal tumor histol…

UNCOMPLICATED ACUTE APPENDICITISAdultumpilisäketulehdusINTERVAL APPENDECTOMYANTIBIOTIC-THERAPYAdenocarcinoma3121 Internal medicineCONSERVATIVE TREATMENTNeuroendocrine tumorhistologiaMANAGEMENTAppendectomyHumansPseudomyxoma peritoneiINCREASED RISKMETAANALYSISMixed adeno-neuroendocrine carcinomapseudomyxoma peritoneiappendicitis severityappendiceal adenocarcinomaGastroenterologyneuroendokriiniset kasvaimetAppendiceal adenocarcinomaSERIESAppendicitisTUMORSAbscesskarsinoomatAppendiceal Neoplasms3121 General medicine internal medicine and other clinical medicineAcute Diseasemixed adeno-neuroendocrine carcinomaAppendicitis severityGoblet cell carcinomaneuroendocrine tumorgoblet cell carcinoma
researchProduct

Asthmatic bronchial lesions in drug addicted

2016

drug abuse bronchial asthma goblet cell metaplasia
researchProduct

Single and Synergistic Effects of Type 2 Cytokines on Eosinophils and Asthma Hallmarks

2020

Abstract The type 2 cytokines IL-5, IL-13, and IL-4 play an important role in the induction and progression of asthma. According to the Global Initiative for Asthma guidelines, blood eosinophil numbers are one marker that helps to guide treatment decisions in patients suffering from severe forms of asthma. Effects of type 2 cytokines were analyzed, alone or in combination, on eosinophils in blood and other compartments and on the development of asthma symptoms. C57BL/6 mice received a single intranasal application of equimolar amounts of IL-5, IL-13, and IL-4, alone or in combination. Numbers, activation state, and migratory behavior of eosinophils in bone marrow (BM), blood, lung, and bron…

medicine.medical_treatmentImmunologyMedizinMice03 medical and health sciencesTh2 Cells0302 clinical medicineMetaplasiamedicineAnimalsHumansImmunology and AllergyEosinophiliaLungCells CulturedAsthmaGoblet cellInterleukin-13Lungmedicine.diagnostic_testbusiness.industryrespiratory systemEosinophilmedicine.diseaseAsthmarespiratory tract diseasesEosinophilsMice Inbred C57BLDisease Models AnimalBronchoalveolar lavagemedicine.anatomical_structureCytokineImmunologyAirway RemodelingFemaleInterleukin-4Interleukin-5medicine.symptombusiness030215 immunologyThe Journal of Immunology
researchProduct

Duchenne Muscular Dystrophy (DMD): Should it be Considered a Systemic Disease?

2016

Duchenne muscular dystrophy (DMD) is an X-linked muscle disease characterized by progressive skeletal muscle loss and development of respiratory failure due to involvement of respiratory muscles. Similar to human DMD, the mdx mouse model lacks dystrophin but is characterized by relatively mild muscle injury, allowing testing the effects of mild endurance exercise training on dystrophic skeletal muscle. We were interested to study the effects of exercise training on airway cells in trained mdx mice by applying the same protocol previously tested in Swiss mice. We found that mdx mice showed little airway inflammation associated with training, but developed increasing apoptosis of airway cells…

musculoskeletal diseasescongenital hereditary and neonatal diseases and abnormalitiesmdx mousePathologymedicine.medical_specialtyAirway epitheliumDuchenne muscular dystrophyNotch pathwaySkeletal muscleSettore MED/10 - Malattie Dell'Apparato RespiratorioBiologymedicine.diseaseChaperonin Hsp60Settore BIO/09 - FisiologiaDystrophinmedicine.anatomical_structureRespiratory failureEndurance trainingmedicinebiology.proteinRespiratory epitheliumRespiratory systemDystrophinGoblet cellSingle Cell Biology
researchProduct